Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sage Therapeutic Com
(NQ:
SAGE
)
10.99
+0.52 (+4.97%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Sage Therapeutic Com
< Previous
1
2
3
4
5
6
7
Next >
Stocks That Hit 52-Week Lows On Tuesday
August 03, 2021
On Tuesday morning, 69 companies achieved new lows for the year. Intriguing Points: Las Vegas Sands (NYSE:LVS) was the largest firm by market cap to set a new 52-...
Via
Benzinga
Sage Therapeutics: Q2 Earnings Insights
August 03, 2021
Shares of Sage Therapeutics (NASDAQ:SAGE) moved higher by 11.9% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 12...
Via
Benzinga
Analyst Ratings For Sage Therapeutics
July 29, 2021
Analysts have provided the following ratings for Sage Therapeutics (NASDAQ:
Via
Benzinga
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
July 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...
Via
Benzinga
Exposures
COVID-19
Earnings Scheduled For August 3, 2021
August 03, 2021
Companies Reporting Before The Bell • Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter. • Stellantis (NYSE:STLA) is expected to...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 27, 2021
During Tuesday's morning session, 216 companies made new 52-week lows. Noteworthy Points: Alibaba Group Holding (NYSE:BABA) was the largest firm by market cap...
Via
Benzinga
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
July 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI...
Via
Benzinga
June’s Best and Worst Performing Russell 1,000 Stocks
June 29, 2021
The month of June, the second quarter and the first half of 2021 are almost in the bag.
Via
Talk Markets
How Bad Is Biogen's Latest Bad News?
June 29, 2021
The drugmaker has had one big clinical setback and another less serious disappointment in recent weeks.
Via
The Motley Fool
What Happened to Sage Therapeutics Stock?
June 21, 2021
Sage has been struggling for some time to bring its flagship antidepressant to the market.
Via
The Motley Fool
Looking For Bargains Among The Rubble
June 20, 2021
Last week was tough. Nearly everything publicly traded took a hit. In this article I drill down into the market to take account of where the damage was the worst, and maybe identify a few bargains...
Via
Talk Markets
Here's Why Sage Therapeutics Tanked This Week
June 19, 2021
The neuroscience-focused biotech company didn't give investors the result they wanted.
Via
The Motley Fool
Biogen Discontinues Tau Antibody Program For Alzheimer's After Mid-Stage Study Flops
June 17, 2021
Biogen Inc (NASDAQ: BIIB) has four other Alzheimer’s candidates in its clinical pipeline behind recently-approved Aduhelm, of which one has just been canned. The...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2021
June 16, 2021
Upgrades According to Piper Sandler, the prior rating for First Bancorp (NASDAQ:
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
June 16, 2021
Morgan Stanley raised NIKE, Inc. (NYSE:NKE) price ta...
Via
Benzinga
44 Biggest Movers From Yesterday
June 16, 2021
Gainers Alzamend Neuro, Inc. (NASDAQ: ALZN) shares jumped 170% to close at $13.50 on Tuesday after the company priced its IPO at $5 per share. Alfi, Inc. (NASDAQ: ALF) shares...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Mid-Afternoon Market Update: Nasdaq Down 100 Points; Clearside Biomedical Shares Spike Higher
June 15, 2021
Toward the end of trading Tuesday, the Dow traded down 0.19% to 34,326.95 while the NASDAQ fell 0.70% to 14,074. The S&P also fell, dropping 0.12% to 4,249.99. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 15, 2021
Gainers Clearside Biomedical (NASDAQ:CLSD) stock moved upwards by 26.21% to $3.81 during Tuesday's regular session. As of 12:30 EST, this security is trading at a...
Via
Benzinga
Here's Why Sage Therapeutics Stock Is Sliding Today
June 15, 2021
Long-awaited clinical trial results weren't as successful as hoped.
Via
The Motley Fool
Mid-Day Market Update: Crude Oil Rises 1%; Sage Therapeutics Shares Slide
June 15, 2021
Midway through trading Tuesday, the Dow traded down 0.45% to 34,238.18 while the NASDAQ fell 0.53% to 14,099.27. The S&P also fell, dropping 0.25% to 4,244.45. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
34 Stocks Moving In Tuesday's Mid-Day Session
June 15, 2021
Gainers HMG/Courtland Properties, Inc. (NYSE: HMG) shares surged 133% to $27.80. Alfi, Inc. (NASDAQ: ALF) shares jumped 82.1% to $6.21 after the company inked an agreement with...
Via
Benzinga
Biogen Analyst Raises Price Target On Higher Chance Of Success For Depression Drug
June 15, 2021
Biogen Inc. (NASDAQ: BIIB) stock is seeing muted sentiment Tuesday as it emerges from the euphoria over Aduhelm approval, with the most recent trigger being lukewarm data for a...
Via
Benzinga
Mid-Morning Market Update: Markets Open Lower; US Retail Sales Drop 1.3% In May
June 15, 2021
Following the market opening Tuesday, the Dow traded down 0.34% to 34,275.92 while the NASDAQ fell 0.09% to 14,161.73. The S&P also fell, dropping 0.10% to 4,250.89. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Sage Stock Tumbles As Analysts Question Its 'Positive' Test In Depression
June 15, 2021
The results showed an improvement over placebo. But that improvement waned over time.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 15, 2021
Gainers Clearside Biomedical (NASDAQ:CLSD) stock increased by 50.99% to $4.56 during Tuesday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
Why Sage Therapeutics (SAGE) Stock Is Falling Despite Meeting Primary Endpoint In Major Depressive Disorder Trial With Zuranolone
June 15, 2021
Looking to make a comeback after a big Phase 3 flop, Sage Therapeutics Inc (NASDAQ: SAGE) revealed data from another Phase 3 evaluating zuranolone in patients with...
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda
June 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS...
Via
Benzinga
Sage Therapeutics - Biogen's Zuranolone Tops Placebo In Reducing Depressive Symptoms
June 15, 2021
Sage Therapeutics Inc (NASDAQ: SAGE) and Biogen Inc (NASDAQ: BIIB) have announced data from WATERFALL Phase 3 study evaluating zuranolone (SAGE-217/...
Via
Benzinga
With Aduhelm Approval Behind Biogen, 5 Catalysts For Investors To Watch
June 10, 2021
Biogen Inc. (NASDAQ: BIIB) made history of sorts with the FDA approval for its Alzheimer's treatment Aduhelm. Notwithstanding the still-raging debate over the decision, an...
Via
Benzinga
Exposures
Product Safety
3 Biotech Stocks With Huge Catalysts in June
June 02, 2021
Binary events expected this month could have enormous implications for these drugmakers and their shareholders.
Via
The Motley Fool
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.